A Framework for Crafting Clinical Practice Guidelines that are Relevant to the Care and Management of People with Multimorbidity
Many patients of all ages have multiple conditions, yet clinicians often lack explicit guidance on how to approach clinical decision-making for such people. Most recommendations from clinical practice guidelines (CPGs) focus on the management of single diseases, and may be harmful or impractical for patients with multimorbidity. A major barrier to the development of guidance for people with multimorbidity stems from the fact that the evidence underlying CPGs derives from studies predominantly focused on the management of a single disease. In this paper, the investigators from the Improving Guidelines for Multimorbid Patients Study Group present consensus-based recommendations for guideline developers to make guidelines more useful for the care of people with multimorbidity. In an iterative process informed by review of key literature and experience, we drafted a list of issues and possible approaches for addressing important coexisting conditions in each step of the guideline development process, with a focus on considering relevant interactions between the conditions, their treatments and their outcomes. The recommended approaches address consideration of coexisting conditions at all major steps in CPG development, from nominating and scoping the topic, commissioning the work group, refining key questions, ranking importance of outcomes, conducting systematic reviews, assessing quality of evidence and applicability, summarizing benefits and harms, to formulating recommendations and grading their strength. The list of issues and recommendations was reviewed and refined iteratively by stakeholders. This framework acknowledges the challenges faced by CPG developers who must make complex judgments in the absence of high-quality or direct evidence. These recommendations require validation through implementation, evaluation and refinement.
KEY WORDSguidelines multimorbidity comorbidity grading evidence
The expert panel included Klara Brunnhuber, Jako S. Burgers, Sheldon Greenfield, Gordon Guyatt, Kevin High, Rosanne Leipzig, Cynthia Mulrow, Kenneth Schmader, Holger Schunemann, Louise C. Walter, and James Woodcock.
We acknowledge Anand Parekh and Kay Dickersin for their attendance for part of the ‘Improving Guidelines for Multimorbid Patients Stakeholder Conference.’
We acknowledge the Participants in the Guideline Breakout Groups who attended the ‘Improving Guidelines for Multimorbid Patients Stakeholder Conference’ (See below), Baltimore, Maryland, Fall 2010
Lewis, Sandra Zelman
This work was funded by AHRQ R21 HS018597-01 (PI Boyd) and AHRQ R21 HS017653. Dr. Boyd’s effort was supported in part by the Johns Hopkins Bayview Center for Innovative Medicine, The Robert Wood Johnson Foundation Physician Faculty Scholars Program, and the Paul Beeson Career Development Award Program (NIA K23 AG032910, AFAR, The John A. Hartford Foundation, The Atlantic Philanthropies, The Starr Foundation, and an anonymous donor). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Walter’s effort was supported by the National Cancer Institute (grant number R01 CA134425) and the National Institute on Aging (grant number K24 AG041180).
Improving Guidelines for Multimorbid Patients Investigator Group
Cynthia Boyd, Johns Hopkins Medical Institutions (JHMI), Sydney Dy, Johns Hopkins Bloomberg School of Public Health (JHSPH), David M. Kent, Tufts Medical Center (TMC), Bruce Leff, JHMI, Jodi Segal (JHMI) Thomas A. Trikalinos, Brown University, Katrin Uhlig, TMC, Ravi Varadhan, JHMI, Carlos Weiss, JHMI.
Conflict of Interest
Dr. Boyd is a co-author of an article on multimorbidity for UpToDate.
- 2.Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the american geriatrics society: american geriatrics society expert panel on the care of older adults with multimorbidity. J Am Geriatr Soc. 2012;60(10):1957–68.Google Scholar
- 4.Fabbri LM, Boyd C, Boschetto P, Rabe KF, Buist AS, Yawn B, et al. How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012;9(5):274–81.PubMedCrossRefGoogle Scholar
- 10.Department of Health and Human Services Strategic Framework on Multiple Chronic Conditions, 2010.Google Scholar
- 11.Weiss CO, Varadhan R, Puhan M, Vickers A, Bandeen-Roche K, Boyd C, et al. Multimorbidity and Evidence Generation. JGIM. 2013, doi: 10.1007/s11606-013-2555-5.
- 16.Trikalinos T, Segal J, Boyd CM. Addressing Multimorbidity in Evidence Integration and Synthesis. JGIM. 2013, doi: 10.1007/s11606-013-2661-4.
- 17.Boyd C, Kent D. Evidence Based Medicine and the Hard Problem of Multimorbidity. JGIM. 2013, doi: 10.1007/s11606-013-2658-z.
- 24.Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, et al. AHRQ Series Paper 5: grading the strength of a body of evidence when comparing medical interventions—Agency for Healthcare Research and Quality and the Effective Health-Care Program. J Clin Epidemiol. 2010;63(5):513–23.PubMedCrossRefGoogle Scholar
- 25.Institute of Medicine. Clinical Practice Guidelines We Can Trust: The National Academies Press, 2011.Google Scholar
- 26.National Institute for Clinical Excellence. Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers. London: National Institute for Clinical Excellence; 2004. Updated 2005.Google Scholar
- 27.U.S. Preventive Services Task Force (USPSTF) Procedure Manual. http://www.uspreventiveservicestaskforce.org/uspstf08/methods/procmanual.htm, Accessed on November 1, 2013.
- 28.Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40(11):1559–85.PubMedCrossRefGoogle Scholar
- 29.KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49(2 Suppl 2):S12–154.Google Scholar
- 36.KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009(113):S1–130.Google Scholar
- 40.MacLean S, Mulla S, Akl EA, Jankowski M, Vandvik PO, Ebrahim S, et al. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e1S–23S.PubMedCentralPubMedGoogle Scholar
- 41.Butler M, Talley KMC, Burns R, Ripley A, Rothman A, Johnson P, et al. Values of Older Adults Related to Primary and Secondary Prevention. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011.Google Scholar
- 52.You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e531S–75S.PubMedCentralPubMedGoogle Scholar
- 58.Framingham Heart Study, http://www.framinghamheartstudy.org/risk/coronary.html, Accessed on September 17, 2013.
- 60.Tinetti ME, McAvay GJ, Chang SS, Newman AB, Fitzpatrick AL, Fried TR, et al. Contribution of multiple chronic conditions to universal health outcomes. J Am Geriatr Soc. 2011;59(9):1686–91.Google Scholar